Immune pathogenesis of hepatocellular carcinoma

被引:281
|
作者
Nakamoto, Y [1 ]
Guidotti, LG [1 ]
Kuhlen, CV [1 ]
Fowler, P [1 ]
Chisari, FV [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, Div Expt Pathol, La Jolla, CA 92037 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 188卷 / 02期
关键词
cytotoxic T lymphocytes; hepatitis B virus; chronic hepatitis; hepatocellular carcinoma; transgenic mice;
D O I
10.1084/jem.188.2.341
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatocellular carcinoma (HCC) is a common complication of chronic hepatitis B virus (HBV) infection. The pathogenetic mechanisms potentially responsible for HCC during chronic HBV infection are not well defined. This study demonstrates that chronic immune-mediated liver cell injury triggers the development of HCC in the absence of viral transactivation, insertional mutagenesis, and genotoxic chemicals. These results strongly suggest that the immune response to HBV is both necessary and sufficient to cause liver cancer during chronic HBV infection, and that all other procarcinogenic events associated with HCC are probably dependent on this process.
引用
收藏
页码:341 / 350
页数:10
相关论文
共 50 条
  • [1] Pathogenesis of hepatocellular carcinoma
    Manns, MP
    Kubicka, S
    2ND INTERNATIONAL CONGRESS ON GASTROENTEROLOGICAL CARCINOGENESIS, 1999, : 65 - 70
  • [2] The Pathogenesis of Hepatocellular Carcinoma
    Kirstein, Martha M.
    Vogel, Arndt
    DIGESTIVE DISEASES, 2014, 32 (05) : 545 - 553
  • [3] Pathogenesis of hepatocellular carcinoma
    Caselmann, WH
    DIGESTION, 1998, 59 : 60 - 63
  • [4] Pathogenesis of hepatocellular carcinoma
    Moradpour, D
    Blum, HE
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (05) : 477 - 483
  • [5] Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma
    Jayant, Kumar
    Habib, Nagy
    Huang, Kai W.
    Warwick, Jane
    Arasaradnam, Ramesh
    DIAGNOSTICS, 2020, 10 (05)
  • [6] Differential procarcinogenic potential of lymphocyte subsets in immune pathogenesis of hepatocellular carcinoma.
    Nakamoto, Y
    Suda, T
    Kaneko, S
    HEPATOLOGY, 2003, 38 (04) : 179A - 179A
  • [7] Immune pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.
    Nakamoto, Y
    Guidotti, LG
    Kuhlen, CV
    Kaneko, S
    Kobayashi, K
    Chisari, FV
    HEPATOLOGY, 1998, 28 (04) : 166A - 166A
  • [8] Fas ligand-dependent inhibition of immune pathogenesis of hepatocellular carcinoma.
    Nakamoto, Y
    Kaneko, S
    Fan, H
    Chisari, FV
    Kobayashi, K
    Suda, T
    HEPATOLOGY, 2001, 34 (04) : 242A - 242A
  • [9] Molecular pathogenesis of hepatocellular carcinoma
    Woerns, M. -A.
    Schuchmann, M.
    Kanzler, S.
    Weinmann, A.
    Galle, P. R.
    GASTROENTEROLOGE, 2007, 2 (01): : 12 - 19
  • [10] Molecular Pathogenesis of Hepatocellular Carcinoma
    Cornella, Helena
    Alsinet, Clara
    Villanueva, Augusto
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (05) : 821 - 825